Top compounds associated with response to PSMD9


Feature Type Standardized
Nominal ANOVA
mRNA ML083 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Docetaxel gCSI pan-cancer AAC 0.034 0.5
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.034 0.5
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.029 0.5
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.027 0.5
mRNA CHIR-99021 CTRPv2 pan-cancer AAC 0.021 0.5
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.034 0.5
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.024 0.5
Download CSV